SPEECH - Dr. Dennis J. Slamon at Revlon�s Annual Philanthropic Luncheon

In the past two years, a new therapy for breast cancer has been developed, targeting the largest segment of breast cancer cases. This therapy, initially not used for breast cancer, has received FDA approval, significantly improving progression-free survival rates. The speaker expresses gratitude to supporters and emphasizes ongoing research efforts to continue making progress in breast cancer treatment.

What new insight or understanding did you gain from this video?